Sign in to continue:

Wednesday, May 6th, 2026

Crawford & Company 2025 Annual Report (10-K): Financials, Risk Factors, and SEC Filing Details





Crawford & Company 2025 Annual Report: Key Investor Insights

Crawford & Company 2025 Annual Report: Key Points and Investor Takeaways

Company Overview

Crawford & Company (“Crawford” or “the Company”), headquartered in Peachtree Corners, Georgia, is a global leader in claims management solutions, serving major insurance carriers, brokers, and corporations. The Company is listed on the New York Stock Exchange under the symbols CRD-A and CRD-B.

Key Highlights from the 2025 Annual Report

  • Fiscal Year End: December 31, 2025
  • Outstanding Shares:
    • Class A Common Stock: 29,688,043 shares
    • Class B Common Stock: 18,985,060 shares
  • Public Float: \$239.8 million as of June 30, 2025
  • Exchange: New York Stock Exchange
  • Industry: Insurance Agents, Brokers & Services (SIC 6411)

Financial Reporting and Compliance

  • The Company filed all reports required by the Securities Exchange Act of 1934 during the past 12 months and has been subject to such filing requirements for the past 90 days.
  • Crawford has also submitted all required Interactive Data Files electronically in accordance with SEC rules.
  • The company is not a well-known seasoned issuer and is not an emerging growth company.
  • The Annual Report includes an attestation report on internal control over financial reporting by its registered public accounting firm, indicating compliance with Section 404(b) of the Sarbanes-Oxley Act.
  • No restatements or corrections of previously issued financial statements were reported, and there were no recovery analyses of incentive-based compensation for executives required during the reporting period.
  • The Company is not a shell company.

Potential Price-Sensitive and Shareholder-Relevant Information

  • Share Structure: The maintenance of two classes of common stock (Class A and Class B) with significant numbers of shares outstanding could affect voting dynamics and market liquidity. Shareholders should be aware of the potential implications for control and influence over corporate matters.
  • Public Float: The public float size (\$239.8 million) is a key metric for institutional investor interest and potential inclusion in indices or investment funds. Changes in float size can impact liquidity and share price volatility.
  • Regulatory Compliance: The absence of financial restatements and the presence of a clean internal control attestation report are important for investor confidence. Any future adverse findings could impact share value.
  • Proxy Statement Reference: Portions of the 2026 proxy statement (to be filed within 120 days of year-end) are incorporated by reference into the 10-K. This proxy will contain further disclosures regarding executive compensation, corporate governance, and board matters—areas that can be highly price-sensitive depending on their content.

Critical Sections for Investors (Table of Contents Preview)

Investors should pay particular attention to certain sections of the full 10-K, as listed in the table of contents:

  • Item 1: Business (Page 1)
  • Item 1A: Risk Factors (Page 6)
  • Item 1C: Cybersecurity (Page 14) – A new and highly relevant section for all stakeholders, given the increasing threat landscape.
  • Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations (Page 18)
  • Item 7A: Quantitative and Qualitative Disclosures about Market Risk (Page 52)
  • Item 8: Financial Statements and Supplementary Data (Page 54)
  • Item 9: Changes in and Disagreements with Accountants on Accounting and Financial Disclosure (Page 105)
  • Item 10: Directors, Executive Officers and Corporate Governance (Page 108)

What May Affect Share Values

  • Risk Factors and Cybersecurity: The upcoming detailed sections on risk factors and cybersecurity could contain material disclosures about operational, market, or cybersecurity risks that, if significant, could impact investor sentiment and share price.
  • Market Risk Disclosures: Section 7A will outline the company’s exposure to interest rates, foreign currencies, and other market risks, which is vital in evaluating financial stability and future earnings potential.
  • No Restatements/No Errors: The fact that there are no restatements or corrections of financial statements and no errors requiring executive compensation clawbacks is a positive for investor trust.
  • Audit Controls: The presence of an unqualified internal controls report further supports the integrity of the financials, which is critical for institutional investors.

Summary

The 2025 Annual Report of Crawford & Company reinforces the company’s commitment to regulatory compliance, transparency, and robust internal controls. Key items for shareholders include the company’s clean financial reporting record, significant public float, and detail on share structure. The upcoming proxy statement and further detailed disclosures in risk and cybersecurity are important for shareholders to monitor, as they may provide information that could affect share price.

Investors are encouraged to review the full 10-K, especially the sections on risk factors, cybersecurity, management’s discussion and analysis, and quantitative disclosures about market risk for additional insights that may influence investment decisions.


Disclaimer: The information contained in this article is a summary and interpretation of Crawford & Company’s 2025 Annual Report as filed with the SEC. It is provided for informational purposes only and should not be construed as investment advice. Shareholders and potential investors should review the company’s full filings and consult their financial advisors before making investment decisions. The author does not accept any liability for investment actions taken based on this summary.




View CRAWFORD & CO Historical chart here



McCormick & Company 8-K Filing March 12, 2026: Common Stock Details, NYSE Listings, and Company Information

McCormick & Co Inc. 8-K Filing: Detailed Investor Report ...

Emergent BioSolutions Q1 2026 Financial Results: Earnings, Revenue, and Key Risk Factors Explained

Emergent BioSolutions Q1 2026 Financial Report - Investor An...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today